These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24957833)

  • 1. Comparative efficacies of cloxacillin-daptomycin and the standard cloxacillin-rifampin therapies against an experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.
    El Haj C; Murillo O; Ribera A; Vivas M; Garcia-Somoza D; Tubau F; Cabo J; Ariza J
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5576-80. PubMed ID: 24957833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of daptomycin-cloxacillin combination in experimental foreign-body infection due to methicillin-resistant Staphylococcus aureus.
    Garrigós C; Murillo O; Lora-Tamayo J; Verdaguer R; Tubau F; Cabellos C; Cabo J; Ariza J
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3806-11. PubMed ID: 22585211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.
    Murillo O; Doménech A; Garcia A; Tubau F; Cabellos C; Gudiol F; Ariza J
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4011-7. PubMed ID: 17015630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daptomycin combinations as alternative therapies in experimental foreign-body infection caused by meticillin-susceptible Staphylococcus aureus.
    El Haj C; Murillo O; Ribera A; Vivas M; Garcia-Somoza D; Tubau F; Cabellos C; Cabo J; Ariza J
    Int J Antimicrob Agents; 2015 Aug; 46(2):189-95. PubMed ID: 26051988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination.
    Cantoni L; Glauser MP; Bille J
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2348-53. PubMed ID: 1965105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fosfomycin-daptomycin and other fosfomycin combinations as alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
    Garrigós C; Murillo O; Lora-Tamayo J; Verdaguer R; Tubau F; Cabellos C; Cabo J; Ariza J
    Antimicrob Agents Chemother; 2013 Jan; 57(1):606-10. PubMed ID: 23089756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of usual and high doses of daptomycin in combination with rifampin versus alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
    Garrigós C; Murillo O; Euba G; Verdaguer R; Tubau F; Cabellos C; Cabo J; Ariza J
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5251-6. PubMed ID: 20921321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive rifampin is crucial to optimizing daptomycin efficacy against rabbit prosthetic joint infection due to methicillin-resistant Staphylococcus aureus.
    Saleh-Mghir A; Muller-Serieys C; Dinh A; Massias L; Crémieux AC
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4589-93. PubMed ID: 21825285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of daptomycin pharmacodynamics and resistance at various dosage regimens against Staphylococcus aureus isolates with reduced susceptibilities to daptomycin in an in vitro pharmacodynamic model with simulated endocardial vegetations.
    Rose WE; Leonard SN; Rybak MJ
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3061-7. PubMed ID: 18591272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Sakoulas G; Eliopoulos GM; Alder J; Eliopoulos CT
    Antimicrob Agents Chemother; 2003 May; 47(5):1714-8. PubMed ID: 12709345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of vancomycin plus cloxacillin compared with vancomycin, cloxacillin and daptomycin single therapies in the treatment of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in a rabbit model of experimental endocarditis.
    Castañeda X; García-De-la-Mària C; Gasch O; Pericàs JM; Soy D; Cañas-Pacheco MA; Falces C; García-González J; Hernández-Meneses M; Vidal B; Almela M; Quintana E; Tolosana JM; Fuster D; Llopis J; Dahl A; Moreno A; Marco F; Miró JM;
    J Antimicrob Chemother; 2021 May; 76(6):1539-1546. PubMed ID: 33837406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Combination of Daptomycin and Fosfomycin Has Synergistic, Potent, and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus in a Rabbit Model of Experimental Endocarditis.
    García-de-la-Mària C; Gasch O; García-Gonzalez J; Soy D; Shaw E; Ambrosioni J; Almela M; Pericàs JM; Tellez A; Falces C; Hernandez-Meneses M; Sandoval E; Quintana E; Vidal B; Tolosana JM; Fuster D; Llopis J; Pujol M; Moreno A; Marco F; Miró JM
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial.
    Cheng MP; Lawandi A; Butler-Laporte G; Paquette K; Lee TC
    Trials; 2018 May; 19(1):297. PubMed ID: 29843781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of high doses of daptomycin versus alternative therapies against experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
    Murillo O; Garrigós C; Pachón ME; Euba G; Verdaguer R; Cabellos C; Cabo J; Gudiol F; Ariza J
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4252-7. PubMed ID: 19635963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin.
    Voorn GP; Kuyvenhoven J; Goessens WH; Schmal-Bauer WC; Broeders PH; Thompson J; Michel MF
    Antimicrob Agents Chemother; 1994 Mar; 38(3):487-93. PubMed ID: 8203842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-biofilm effect of macrolides in a rat model of S. aureus foreign-body infection: Might it be of clinical relevance?
    El Haj C; Murillo O; Ribera A; Garcia-Somoza D; Tubau F; Cabellos C; Cabo J; Ariza J
    Med Microbiol Immunol; 2017 Feb; 206(1):31-39. PubMed ID: 27639707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus.
    Lucet JC; Herrmann M; Rohner P; Auckenthaler R; Waldvogel FA; Lew DP
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2312-7. PubMed ID: 2128441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin.
    Ahmad NM; Rojtman AD
    Ann Pharmacother; 2010 May; 44(5):918-21. PubMed ID: 20354160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of daptomycin in implant-associated infection due to methicillin-resistant Staphylococcus aureus: importance of combination with rifampin.
    John AK; Baldoni D; Haschke M; Rentsch K; Schaerli P; Zimmerli W; Trampuz A
    Antimicrob Agents Chemother; 2009 Jul; 53(7):2719-24. PubMed ID: 19364845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of tigecycline alone and with rifampin in foreign-body infection by methicillin-resistant Staphylococcus aureus.
    Garrigós C; Murillo O; Euba G; Verdaguer R; Tubau F; Cabellos C; Cabo J; Ariza J
    J Infect; 2011 Sep; 63(3):229-35. PubMed ID: 21763722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.